WHO ICTRP trial
A double-blind, placebo-controlled, parallel group, proof of concept trial to…
EUCTR2005-004290-19-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-004290-19-DE |
|---|---|
| Public title | A double-blind, placebo-controlled, parallel group, proof of concept trial to assess the tolerabiltiy, safety and efficacy of rotigotine nasal spray for the acute treatment of 'off' symptoms in subjects with advanced-stage, idiopathic Parkinson's disease |
| Scientific title | A double-blind, placebo-controlled, parallel group, proof of concept trial to assess the tolerabiltiy, safety and efficacy of rotigotine nasal spray for the acute treatment of 'off' symptoms in subjects with advanced-stage, idiopathic Parkinson's disease |
| Primary sponsor | Schwarz Biosciences GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom;Germany;Spain |
| Conditions | advanced-stage, idiopathic Parkinson's disease MedDRA version: 8.1 Level: LLT Classification code 10061536 |
| Interventions | Product Name: Rotigotine Nasal Spray Product Code: ND1421 Pharmaceutical Form: Nasal spray, solution INN or Proposed INN: Rotigotine hydrochloride CAS Number: 125572-93-2 Concentration unit: mg/ml milligram(s)/millilitre Concentration type… |
| Registration date | May 12, 2005 |
| Target size | 100 |
| Secondary IDs | SP873 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: